Outcomes of patients with thyroid nodules clinically tested using a combination of mutation and microRNA classification: Interim results of a clinical experience study

ATA 2018 Washington DC
We report interim results of a multicenter registry study of patients with thyroid nodules indeterminate by cytology that underwent combined mutation (ThyGenX®) and microRNA (ThyraMIR®) testing in clinical practice. We examined the likelihood at which patients avoided surgery and survived without developing malignancy given combined test results.
Scroll to Top